|
2024
|
Invention
|
Treatment of p53 gene mutation or defect negative cancer and tumor patients. A method of using a ... |
|
|
Invention
|
Solid dispersion containing dimethyl sulfone, and use thereof. A solid dispersion containing dime... |
|
|
Invention
|
Correlation of akr1c3 enzyme expression level with kras mutation, and medical use. Correlation of... |
|
|
Invention
|
Injection preparation and preparation method therefor, and compatible medicinal liquid and prepar... |
|
|
Invention
|
Solution, freeze-dried formulation, freeze-dried formulation unit package, injection, and injecti... |
|
2023
|
Invention
|
Gemcitabine anti-cancer derivative, anti-cancer pharmaceutical use and preparation method therefo... |
|
|
Invention
|
Combination of akr1c3 activated anticancer prodrug compound and analgesic drug for treating cance... |
|
|
Invention
|
Use of hypoxia-activated compound in preparation of medicament for treating cancer patient. Provi... |
|
|
Invention
|
Ast-3424 combination for treating leukemia and lymphoma. A treatment method, comprising using a d... |
|
|
Invention
|
Synthesis process of x-ipm, stable crystal form and application thereof.
The present application... |
|
|
Invention
|
Preparation process of intermediate, synthesis process of amino imidazole carboxylate ester and h... |
|
|
Invention
|
Preparation process of 1-n-methyl-2-nitro-5-hydroxymethyl imidazole.
The present invention provi... |
|
|
Invention
|
Method for treating cancer patient with akr1c3 enzyme-activated prodrug. Provided is treatment of... |
|
|
Invention
|
Method for treating cancer by combining alkylating agent prodrug and cell cycle inhibitor. Provid... |
|
|
Invention
|
Method for treating cancer by using th-302 alone or in combination with parp inhibitor. The prese... |
|
|
Invention
|
Method for treating patient with brca-mutated cancer. A method for treating BRCA gene-mutated can... |
|
2022
|
Invention
|
Stable ast-3424 api product, preparation method therefor, and storage thereof. Provided are a sta... |
|
|
Invention
|
Treatment of cancer patients having kras mutations. A method for treating cancer and tumor patien... |
|
|
Invention
|
Lyophilized formulation solution and lyophilized formulation, and method and use thereof.
Provid... |
|
|
Invention
|
Lyophilized formulation solution and lyophilized formulation, and method and use thereof. Provide... |
|
|
Invention
|
Parp inhibitor-resistant patient treated with th-302. The present invention provides a treatment ... |
|
|
Invention
|
Gemcitabine anticancer derivative and anticancer pharmaceutical use.
The present invention provi... |
|
|
Invention
|
Gemcitabine anticancer derivative and anticancer pharmaceutical use. The present invention provid... |
|
|
Invention
|
Recombinant oncolytic virus and medical use thereof. Provided is a recombinant oncolytic virus ob... |
|
2021
|
Invention
|
Use of tipranavir in preparing cancer therapy drugs for killing tumor stem cells and tumor cells.... |
|
|
Invention
|
A deuterated compound, and preparation method and use thereof.
Described is a deuterated compoun... |
|
|
Invention
|
Deuterated compound, and preparation method therefor and use thereof. A deuterated compound, and ... |
|
|
Invention
|
Akr1c3-activated dna alkylating agent, and medical application thereof. An AKR1C3-activated DNA a... |
|
|
Invention
|
Akr1c3 detection method, and diagnostic kit for detecting akr1c3 and use thereof.
An AKR1C3 dete... |
|
|
Invention
|
Akr1c3 detection method, and diagnostic kit for detecting akr1c3 and use thereof. An AKR1C3 detec... |
|
|
Invention
|
Hypoxia-activated dna alkylating agent and medical use thereof.
Described are hypoxia-activated ... |
|
|
Invention
|
Hypoxia-activated dna alkylating agent and medical use thereof. The present invention relates to ... |
|
|
Invention
|
Primer-probe composition, kit, and detection method.
The present invention relates to a primer-p... |
|
|
Invention
|
Primer-probe composition, kit, and detection method. The present invention relates to a primer-pr... |
|
|
Invention
|
Use of akr1c3-activated compound. Provided are the use of the compound 1-(3-(3-N,N-dimethylaminoc... |
|
2020
|
Invention
|
Method for associating with expression level of akr1c3 enzyme via content of prostaglandin, and u... |
|
|
Invention
|
Orally administered solid dosage form drug.
An orally administered solid dosage form drug for tr... |
|
|
Invention
|
Anti-cancer compounds acting as non-pgp substrate.
Provided are anti-cancer compounds which act ... |
|
|
Invention
|
Orally administered solid dosage form drug. An orally administered solid dosage form drug for tre... |
|
|
Invention
|
Anti-cancer compounds acting as non-pgp substrate. Provided are anti-cancer compounds which act a... |
|
|
Invention
|
Anticancer compound and medical use thereof.
A compound of formula (I), or pharmaceutically acce... |
|
|
Invention
|
Anticancer compound and medical use thereof. The present invention provides a compound of formula... |
|
|
Invention
|
Packaging bottle and packaging kit for injection, and filling, stoppering and capping device and ... |
|
|
Invention
|
Akr1c3 inhibitor and medical use.
Described are compounds that act as AKR1C3 inhibitors or pharm... |
|
|
Invention
|
Fluorine-containing compound and anti-cancer medical use thereof.
The present invention provides... |
|
|
P/S
|
Analgesics; drug delivery agents in the form of powders that provide controlled release of the ac... |
|
|
P/S
|
Analgesics; drugs for medical purposes; chemical reagents
for medical or veterinary purposes; bi... |
|
2019
|
Invention
|
Use of compound in drug for preventing, treating, or alleviating pain.
The present invention pro... |
